Korean J Otorhinolaryngol-Head Neck Surg.  2020 Dec;63(12):615-619. 10.3342/kjorl-hns.2020.00787.

Hurthle Cell Carcinoma of the Thyroid: A Case Report of 12 Cases

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Science, Seoul, Korea

Abstract

Hurthle cell carcinoma (HCC) is a relatively rare disease, which comprises about 3% of differentiated thyroid carcinoma. HCC is considered to have more aggressive clinical behavior compared with other differentiated thyroid carcinoma. However, there has been no consensus about clinical behavior and optimal treatment of HCC because of insufficient reports. Moreover, owing to geographical characteristics, HCC is rarer in Korea than in western countries. Based on 2017 World Health Organization classification, HCC is newly classified as an individual group, not as a subtype of follicular thyroid carcinoma. Therefore, we report data of 12 HCC patients who underwent surgery in our center from January 2000 to May 2020 with a review of the literature.

Keyword

Hurthle cell; Prognosis; Thyroid carcinoma; Thyroidectomy

Cited by  1 articles

Comparative Analysis About Clinical Manifestation and Prognostic Factors of Thyroid Follicular and Hurthle Cell Carcinoma
Jung Jun Kim, Brian Kim, Ik Joon Choi, Byeong-Cheol Lee, Jung Min Ahn, Joon Seog Kong, Myung-Chul Lee
Korean J Otorhinolaryngol-Head Neck Surg. 2021;64(12):906-913.    doi: 10.3342/kjorl-hns.2021.00612.

Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr